News

The study termed as protocol C-400-02 will enroll 75 HSV-2 positive patients to test the efficacy of the HerpV vaccine as measured by effect on genital viral shedding.

The patents include application No.12/702,889 and 13/349,153 for the use of Amarin’s product, Vascepa (icosapent ethyl) capsules, as a treatment for hypertriglyceridemia. Amarin chairman and chief executive officer

Tracking Drugs@FDA and Orange Book Patent Data gives analysis of FDA market intelligence, according to the company. EvaluatePharma research head Anthony Raeside said, "Through our proprietary software platform

Using B-SMART, LabCorp will develop assay that will combine nucleic acid testing with phage-based technology to recognise any resistance of M. tuberculosis clinical isolates to antitubercular antibiotics, irrespective

The grant spread for a year will support research identified by PTC’s proprietary GEMS technology that demonstrates activity against the dengue virus. PTC grant collaborator Eva Harris said,

As part of the alliance, Forest will provide nearly $125m to moksha8 in several phases over a two-year period, provided moksha8 meets certain business goals and will also

Pliaglis, a topical local anesthetic cream forms a pliable peel on the skin and is used on skin of adults to provide local analgesia for superficial aesthetic procedures,

The 2 day QP GMP passing facilitates the company to advance clinical development of its universal flu vaccine, M-001, in the EU. BiondVax will also collaborate with MonoSol

In the second quarter of 2012, Pfizer signed an option and merger agreement with NextWave and made a $20m option payment. At present Pfizer is executing its option